aluates Reports

$ 0.0

Automative

Global Tumor Detection Services Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-38D18036

BUY CHAPTERS

Global Tumor Detection Services Market Research Report 2024

Code: QYRE-Auto-38D18036

Report

October 2024

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Nonacus, Inc.

Natera

Penn Medicine

AMADIX

Rarecells

GRAIL

Bio-Techne

ICAD

Caris Life Sciences

Novocure

Circulogene

Guardant Health

Veracyte, Inc.

Foundation Medicine

Oncologica

Elypta

Dxcover

Haystack Oncology

Tumor Detection Services Market

Tumor detection services are medical services that aim to detect and diagnose cancer at an early stage through a series of medical examinations and tests. These services typically include imaging examinations (such as CT, MRI, ultrasound), laboratory tests (such as blood tests, tumor marker tests), and tissue biopsies. By analyzing the patient's symptoms, medical history, and test results, doctors can assess the presence and type of cancer and develop personalized treatment plans. Early detection can significantly improve cure and survival rates and promote overall health management for patients.

The global Tumor Detection Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Tumor Detection Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tumor Detection Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Tumor Detection Services in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Tumor Detection Services include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor Detection Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Detection Services.

The Tumor Detection Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Detection Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Detection Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor Detection Services Market Report

Report Metric	Details
Report Name	Tumor Detection Services Market
Segment by Type	Non-Invasive Examination Invasive Examination
Segment by Application	Adults Children
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, Dxcover, Caris Life Sciences, Novocure, Circulogene, Guardant Health, Veracyte, Haystack Oncology, Foundation Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Detection Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Detection Services Market report?

Ans: The main players in the Tumor Detection Services Market are Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta, Bio-Techne, iCAD, Dxcover, Caris Life Sciences, Novocure, Circulogene, Guardant Health, Veracyte, Haystack Oncology, Foundation Medicine

What are the Application segmentation covered in the Tumor Detection Services Market report?

Ans: The Applications covered in the Tumor Detection Services Market report are Adults, Children

What are the Type segmentation covered in the Tumor Detection Services Market report?

Ans: The Types covered in the Tumor Detection Services Market report are Non-Invasive Examination, Invasive Examination

Recommended Reports

Cancer Diagnostics

Tumor Marker Testing

Emerging Diagnostic Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Detection Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Non-Invasive Examination

1.2.3 Invasive Examination

1.3 Market by Application

1.3.1 Global Tumor Detection Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Adults

1.3.3 Children

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor Detection Services Market Perspective (2019-2030)

2.2 Global Tumor Detection Services Growth Trends by Region

2.2.1 Global Tumor Detection Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tumor Detection Services Historic Market Size by Region (2019-2024)

2.2.3 Tumor Detection Services Forecasted Market Size by Region (2025-2030)

2.3 Tumor Detection Services Market Dynamics

2.3.1 Tumor Detection Services Industry Trends

2.3.2 Tumor Detection Services Market Drivers

2.3.3 Tumor Detection Services Market Challenges

2.3.4 Tumor Detection Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor Detection Services Players by Revenue

3.1.1 Global Top Tumor Detection Services Players by Revenue (2019-2024)

3.1.2 Global Tumor Detection Services Revenue Market Share by Players (2019-2024)

3.2 Global Tumor Detection Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tumor Detection Services Revenue

3.4 Global Tumor Detection Services Market Concentration Ratio

3.4.1 Global Tumor Detection Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Detection Services Revenue in 2023

3.5 Global Key Players of Tumor Detection Services Head office and Area Served

3.6 Global Key Players of Tumor Detection Services, Product and Application

3.7 Global Key Players of Tumor Detection Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Detection Services Breakdown Data by Type

4.1 Global Tumor Detection Services Historic Market Size by Type (2019-2024)

4.2 Global Tumor Detection Services Forecasted Market Size by Type (2025-2030)

5 Tumor Detection Services Breakdown Data by Application

5.1 Global Tumor Detection Services Historic Market Size by Application (2019-2024)

5.2 Global Tumor Detection Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tumor Detection Services Market Size (2019-2030)

6.2 North America Tumor Detection Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Tumor Detection Services Market Size by Country (2019-2024)

6.4 North America Tumor Detection Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor Detection Services Market Size (2019-2030)

7.2 Europe Tumor Detection Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Tumor Detection Services Market Size by Country (2019-2024)

7.4 Europe Tumor Detection Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor Detection Services Market Size (2019-2030)

8.2 Asia-Pacific Tumor Detection Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Tumor Detection Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Tumor Detection Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor Detection Services Market Size (2019-2030)

9.2 Latin America Tumor Detection Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Tumor Detection Services Market Size by Country (2019-2024)

9.4 Latin America Tumor Detection Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor Detection Services Market Size (2019-2030)

10.2 Middle East & Africa Tumor Detection Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Tumor Detection Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Tumor Detection Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nonacus

11.1.1 Nonacus Company Details

11.1.2 Nonacus Business Overview

11.1.3 Nonacus Tumor Detection Services Introduction

11.1.4 Nonacus Revenue in Tumor Detection Services Business (2019-2024)

11.1.5 Nonacus Recent Development

11.2 Natera

11.2.1 Natera Company Details

11.2.2 Natera Business Overview

11.2.3 Natera Tumor Detection Services Introduction

11.2.4 Natera Revenue in Tumor Detection Services Business (2019-2024)

11.2.5 Natera Recent Development

11.3 Penn Medicine

11.3.1 Penn Medicine Company Details

11.3.2 Penn Medicine Business Overview

11.3.3 Penn Medicine Tumor Detection Services Introduction

11.3.4 Penn Medicine Revenue in Tumor Detection Services Business (2019-2024)

11.3.5 Penn Medicine Recent Development

11.4 Amadix

11.4.1 Amadix Company Details

11.4.2 Amadix Business Overview

11.4.3 Amadix Tumor Detection Services Introduction

11.4.4 Amadix Revenue in Tumor Detection Services Business (2019-2024)

11.4.5 Amadix Recent Development

11.5 Oncologica

11.5.1 Oncologica Company Details

11.5.2 Oncologica Business Overview

11.5.3 Oncologica Tumor Detection Services Introduction

11.5.4 Oncologica Revenue in Tumor Detection Services Business (2019-2024)

11.5.5 Oncologica Recent Development

11.6 Rarecells

11.6.1 Rarecells Company Details

11.6.2 Rarecells Business Overview

11.6.3 Rarecells Tumor Detection Services Introduction

11.6.4 Rarecells Revenue in Tumor Detection Services Business (2019-2024)

11.6.5 Rarecells Recent Development

11.7 GRAIL

11.7.1 GRAIL Company Details

11.7.2 GRAIL Business Overview

11.7.3 GRAIL Tumor Detection Services Introduction

11.7.4 GRAIL Revenue in Tumor Detection Services Business (2019-2024)

11.7.5 GRAIL Recent Development

11.8 Elypta

11.8.1 Elypta Company Details

11.8.2 Elypta Business Overview

11.8.3 Elypta Tumor Detection Services Introduction

11.8.4 Elypta Revenue in Tumor Detection Services Business (2019-2024)

11.8.5 Elypta Recent Development

11.9 Bio-Techne

11.9.1 Bio-Techne Company Details

11.9.2 Bio-Techne Business Overview

11.9.3 Bio-Techne Tumor Detection Services Introduction

11.9.4 Bio-Techne Revenue in Tumor Detection Services Business (2019-2024)

11.9.5 Bio-Techne Recent Development

11.10 iCAD

11.10.1 iCAD Company Details

11.10.2 iCAD Business Overview

11.10.3 iCAD Tumor Detection Services Introduction

11.10.4 iCAD Revenue in Tumor Detection Services Business (2019-2024)

11.10.5 iCAD Recent Development

11.11 Dxcover

11.11.1 Dxcover Company Details

11.11.2 Dxcover Business Overview

11.11.3 Dxcover Tumor Detection Services Introduction

11.11.4 Dxcover Revenue in Tumor Detection Services Business (2019-2024)

11.11.5 Dxcover Recent Development

11.12 Caris Life Sciences

11.12.1 Caris Life Sciences Company Details

11.12.2 Caris Life Sciences Business Overview

11.12.3 Caris Life Sciences Tumor Detection Services Introduction

11.12.4 Caris Life Sciences Revenue in Tumor Detection Services Business (2019-2024)

11.12.5 Caris Life Sciences Recent Development

11.13 Novocure

11.13.1 Novocure Company Details

11.13.2 Novocure Business Overview

11.13.3 Novocure Tumor Detection Services Introduction

11.13.4 Novocure Revenue in Tumor Detection Services Business (2019-2024)

11.13.5 Novocure Recent Development

11.14 Circulogene

11.14.1 Circulogene Company Details

11.14.2 Circulogene Business Overview

11.14.3 Circulogene Tumor Detection Services Introduction

11.14.4 Circulogene Revenue in Tumor Detection Services Business (2019-2024)

11.14.5 Circulogene Recent Development

11.15 Guardant Health

11.15.1 Guardant Health Company Details

11.15.2 Guardant Health Business Overview

11.15.3 Guardant Health Tumor Detection Services Introduction

11.15.4 Guardant Health Revenue in Tumor Detection Services Business (2019-2024)

11.15.5 Guardant Health Recent Development

11.16 Veracyte

11.16.1 Veracyte Company Details

11.16.2 Veracyte Business Overview

11.16.3 Veracyte Tumor Detection Services Introduction

11.16.4 Veracyte Revenue in Tumor Detection Services Business (2019-2024)

11.16.5 Veracyte Recent Development

11.17 Haystack Oncology

11.17.1 Haystack Oncology Company Details

11.17.2 Haystack Oncology Business Overview

11.17.3 Haystack Oncology Tumor Detection Services Introduction

11.17.4 Haystack Oncology Revenue in Tumor Detection Services Business (2019-2024)

11.17.5 Haystack Oncology Recent Development

11.18 Foundation Medicine

11.18.1 Foundation Medicine Company Details

11.18.2 Foundation Medicine Business Overview

11.18.3 Foundation Medicine Tumor Detection Services Introduction

11.18.4 Foundation Medicine Revenue in Tumor Detection Services Business (2019-2024)

11.18.5 Foundation Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Nonacus, Inc.

Natera

Penn Medicine

AMADIX

Rarecells

GRAIL

Bio-Techne

ICAD

Caris Life Sciences

Novocure

Circulogene

Guardant Health

Veracyte, Inc.

Foundation Medicine

Oncologica

Elypta

Dxcover

Haystack Oncology

List of Tables

Table 1. Global Tumor Detection Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Non-Invasive Examination

Table 3. Key Players of Invasive Examination

Table 4. Global Tumor Detection Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Tumor Detection Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Tumor Detection Services Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Tumor Detection Services Market Share by Region (2019-2024)

Table 8. Global Tumor Detection Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Tumor Detection Services Market Share by Region (2025-2030)

Table 10. Tumor Detection Services Market Trends

Table 11. Tumor Detection Services Market Drivers

Table 12. Tumor Detection Services Market Challenges

Table 13. Tumor Detection Services Market Restraints

Table 14. Global Tumor Detection Services Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Tumor Detection Services Market Share by Players (2019-2024)

Table 16. Global Top Tumor Detection Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Detection Services as of 2023)

Table 17. Ranking of Global Top Tumor Detection Services Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Tumor Detection Services Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Tumor Detection Services, Headquarters and Area Served

Table 20. Global Key Players of Tumor Detection Services, Product and Application

Table 21. Global Key Players of Tumor Detection Services, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tumor Detection Services Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Tumor Detection Services Revenue Market Share by Type (2019-2024)

Table 25. Global Tumor Detection Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Tumor Detection Services Revenue Market Share by Type (2025-2030)

Table 27. Global Tumor Detection Services Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Tumor Detection Services Revenue Market Share by Application (2019-2024)

Table 29. Global Tumor Detection Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Tumor Detection Services Revenue Market Share by Application (2025-2030)

Table 31. North America Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Tumor Detection Services Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Tumor Detection Services Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Tumor Detection Services Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Tumor Detection Services Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Tumor Detection Services Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Tumor Detection Services Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Tumor Detection Services Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Tumor Detection Services Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Tumor Detection Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Tumor Detection Services Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Tumor Detection Services Market Size by Country (2025-2030) & (US$ Million)

Table 46. Nonacus Company Details

Table 47. Nonacus Business Overview

Table 48. Nonacus Tumor Detection Services Product

Table 49. Nonacus Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 50. Nonacus Recent Development

Table 51. Natera Company Details

Table 52. Natera Business Overview

Table 53. Natera Tumor Detection Services Product

Table 54. Natera Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 55. Natera Recent Development

Table 56. Penn Medicine Company Details

Table 57. Penn Medicine Business Overview

Table 58. Penn Medicine Tumor Detection Services Product

Table 59. Penn Medicine Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 60. Penn Medicine Recent Development

Table 61. Amadix Company Details

Table 62. Amadix Business Overview

Table 63. Amadix Tumor Detection Services Product

Table 64. Amadix Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 65. Amadix Recent Development

Table 66. Oncologica Company Details

Table 67. Oncologica Business Overview

Table 68. Oncologica Tumor Detection Services Product

Table 69. Oncologica Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 70. Oncologica Recent Development

Table 71. Rarecells Company Details

Table 72. Rarecells Business Overview

Table 73. Rarecells Tumor Detection Services Product

Table 74. Rarecells Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 75. Rarecells Recent Development

Table 76. GRAIL Company Details

Table 77. GRAIL Business Overview

Table 78. GRAIL Tumor Detection Services Product

Table 79. GRAIL Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 80. GRAIL Recent Development

Table 81. Elypta Company Details

Table 82. Elypta Business Overview

Table 83. Elypta Tumor Detection Services Product

Table 84. Elypta Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 85. Elypta Recent Development

Table 86. Bio-Techne Company Details

Table 87. Bio-Techne Business Overview

Table 88. Bio-Techne Tumor Detection Services Product

Table 89. Bio-Techne Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 90. Bio-Techne Recent Development

Table 91. iCAD Company Details

Table 92. iCAD Business Overview

Table 93. iCAD Tumor Detection Services Product

Table 94. iCAD Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 95. iCAD Recent Development

Table 96. Dxcover Company Details

Table 97. Dxcover Business Overview

Table 98. Dxcover Tumor Detection Services Product

Table 99. Dxcover Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 100. Dxcover Recent Development

Table 101. Caris Life Sciences Company Details

Table 102. Caris Life Sciences Business Overview

Table 103. Caris Life Sciences Tumor Detection Services Product

Table 104. Caris Life Sciences Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 105. Caris Life Sciences Recent Development

Table 106. Novocure Company Details

Table 107. Novocure Business Overview

Table 108. Novocure Tumor Detection Services Product

Table 109. Novocure Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 110. Novocure Recent Development

Table 111. Circulogene Company Details

Table 112. Circulogene Business Overview

Table 113. Circulogene Tumor Detection Services Product

Table 114. Circulogene Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 115. Circulogene Recent Development

Table 116. Guardant Health Company Details

Table 117. Guardant Health Business Overview

Table 118. Guardant Health Tumor Detection Services Product

Table 119. Guardant Health Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 120. Guardant Health Recent Development

Table 121. Veracyte Company Details

Table 122. Veracyte Business Overview

Table 123. Veracyte Tumor Detection Services Product

Table 124. Veracyte Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 125. Veracyte Recent Development

Table 126. Haystack Oncology Company Details

Table 127. Haystack Oncology Business Overview

Table 128. Haystack Oncology Tumor Detection Services Product

Table 129. Haystack Oncology Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 130. Haystack Oncology Recent Development

Table 131. Foundation Medicine Company Details

Table 132. Foundation Medicine Business Overview

Table 133. Foundation Medicine Tumor Detection Services Product

Table 134. Foundation Medicine Revenue in Tumor Detection Services Business (2019-2024) & (US$ Million)

Table 135. Foundation Medicine Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Tumor Detection Services Picture

Figure 2. Global Tumor Detection Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Tumor Detection Services Market Share by Type: 2023 VS 2030

Figure 4. Non-Invasive Examination Features

Figure 5. Invasive Examination Features

Figure 6. Global Tumor Detection Services Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Tumor Detection Services Market Share by Application: 2023 VS 2030

Figure 8. Adults Case Studies

Figure 9. Children Case Studies

Figure 10. Tumor Detection Services Report Years Considered

Figure 11. Global Tumor Detection Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Tumor Detection Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Tumor Detection Services Market Share by Region: 2023 VS 2030

Figure 14. Global Tumor Detection Services Market Share by Players in 2023

Figure 15. Global Top Tumor Detection Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Detection Services as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Tumor Detection Services Revenue in 2023

Figure 17. North America Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Tumor Detection Services Market Share by Country (2019-2030)

Figure 19. United States Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Tumor Detection Services Market Share by Country (2019-2030)

Figure 23. Germany Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Tumor Detection Services Market Share by Region (2019-2030)

Figure 31. China Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Tumor Detection Services Market Share by Country (2019-2030)

Figure 39. Mexico Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Tumor Detection Services Market Share by Country (2019-2030)

Figure 43. Turkey Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE Tumor Detection Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Nonacus Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 47. Natera Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 48. Penn Medicine Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 49. Amadix Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 50. Oncologica Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 51. Rarecells Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 52. GRAIL Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 53. Elypta Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 54. Bio-Techne Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 55. iCAD Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 56. Dxcover Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 57. Caris Life Sciences Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 58. Novocure Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 59. Circulogene Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 60. Guardant Health Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 61. Veracyte Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 62. Haystack Oncology Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 63. Foundation Medicine Revenue Growth Rate in Tumor Detection Services Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cancer Early Detection and Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mobile Cancer Screening Devices Market Insights Forecast to 2030

Global Cancer Early Detection Market Research Report 2025

Global Early Detection of Multiple Cancers Market Research Report 2024

Global Tumor Detection Kit Market Research Report 2024

Blood Cancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiology Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Clinical Imaging Solutions Market Research Report 2025

Global Lung Cancer Diagnostic And Screening Market Research Report 2024

Global Breast Cancer Testing Market Insights Forecast to 2030

Precision Cancer Imaging Market

Global Oncology Imaging Equipment Market Research Report 2024

Multicancer Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Marker Detection Market Research Report 2025

Tumor Early Screening Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non invasive Tumor Detection Market Research Report 2024

Global CTC Detection Market Research Report 2025

Tumor Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Solid Tumor Detection Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions